Nanoscale Gimlet May Give Weakened Antibiotics a Kick
A two-ingredient antibacterial cocktail is more potent than either ingredient alone, even though one of the ingredients is meropenem, an antibiotic that induces multidrug resistance in bacteria. This surprising outcome depends on a twist—or...
Study shows novel protein plays role in bacterial vaginosis
UArizona College of Medicine — Phoenix study increases understanding of most common bacterial infection in US women
Credit: Image Courtesy of Dr. Melissa Herbst-Kralovetz Lab, UArizona College of Medicine – Phoenix.
Molecular drills target and destroy deadly superbugs
Molecular drills have gained the ability to target and destroy deadly bacteria that have evolved resistance to nearly all antibiotics. In some cases, the drills make the antibiotics effective once again.
Researchers at Rice University,...
From CRISPR Multiplexing to Pleistocene Park
George Church, PhD, sits with Kevin Davies at Harvard Medical School to sample some of the many research highlights and ethical quandaries posed by his lab’s endeavors . . .
The post From CRISPR Multiplexing...
Developments in the search for a Zika vaccine – success in mice and a...
Researchers at the University of Adelaide in Australia have created a vaccine that has proved successful at protecting mice against the Zika virus. Meanwhile, researchers at the University of Queensland have discovered a new...
A guidebook for local governments and CBOs to support elderly people to take out...
Credit: NIES
One of the issues related to waste management in aging society is helping elderly people who find it difficult to take out the trash. In...
A recombinant platform for flavivirus vaccines and diagnostics using chimeras
A new technology to produce safer ‘hybrid’ viruses at high volumes for use in vaccines and diagnostics for mosquito-borne diseases has been developed at The University of Queensland.
Researchers from UQ and QIMR Berghofer Medical...
Vietnamese investors support novel technology for ultra-rapid detection of pathogens
Hememics Biotechnologies Inc., ("Hememics" or the "Company") announced that AMVI Partners, a consortium of high net worth Vietnamese investors, has invested $2.5 million into Hememics. The company will use the funds to initiate clinical...
Peering into the Crystal Ball for 2020
Four experts in life sciences and digital health development, commercialization, and investment peered into their proverbial crystal balls to offer insights on “What’s Hot in Life Sciences: A Look at the 2019 Trends and...
Phoenix Biotechnology Announces Completion of Private Placement – Business Wire
SAN ANTONIO--(BUSINESS WIRE)--Phoenix Biotechnology, Inc. (“Phoenix” or the “Company” www.phoenixbiotechnology.com) today announced that it has completed the private placement of 1,373,400 shares of common stock for gross proceeds of $4,120,200.
The gross proceeds of the...
